Latest papers

Age-related differences in plasma proteins: how plasma proteins change from neonates to adults.

γH2AX foci as a measure of DNA damage: a computational approach to automatic analysis.

Recommendations for the validation of flow cytometric testing during drug development: II assays.

Validity studies of quality of life instruments for eating disorders: systematic review of the literature.

Dietary supplements, quality scores and missing data in the review of validation studies.

Dietary supplements, quality scores and missing data in the review of validation studies.

The standardization-generalization dilemma: a way out.

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.

Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis.

Swedish mutation within amyloid precursor protein modulates global gene expression towards the pathogenesis of Alzheimer's disease.

National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers.

Variation in oxytocin is related to variation in affiliative behavior in monogamous, pairbonded tamarins.

Reducing seclusion and restraint: questionnaire for organizational assessment.

Regulation of autophagy by ATF4 in response to severe hypoxia.

miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.

Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1.

The NADPH oxidases NOX4 and DUOX2 regulate cell cycle entry via a p53-dependent pathway.

The bottom-up approach to integrative validity: a new perspective for program evaluation.

Decreased expression of S100A6 in oral squamous cell carcinoma.

System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.